Annie Wong-Beringer, PharmD, FCCP, FIDSA
Associate Dean for Research and Graduate Education
Professor of Clinical Pharmacy
- Bacterial resistance and virulence
- host microbial interactions
- host immune response
- PSC 208A
- (323) 442-1356
- (626) 628-3024
PharmD - USC School of Pharmacy
Postdoctoral Research Fellowship:
Residency & Fellowship in Infectious Diseases, UCSF School of Pharmacy
Anti-Infective Pharmacology Research
Clinicians are faced with an ever-increasing tide of antimicrobial resistance coupled with the dwindling antibiotic development of novel agents to treat infections caused by multi-drug resistant bacteria, specifically, MRSA and Pseudomonas aeruginosa. Our laboratory combines a molecular and pharmacological approach to address this therapeutic challenge.
Our group focuses on gaining a deeper understanding of host-microbial interactions during acute and chronic infections with the goal of identifying potential therapeutic target against bacterial virulence or modulation of host response. We will exploit existing therapies with known safety profiles as well as novel therapies in drug development. Our research program encompasses in vitro cellular models of infection, epidemiologic and outcomes studies, and prospective clinical trials.
Annie Wong-Beringer , Pharm.D., FCCP, FIDSA Associate Dean of Graduate Affairs and Interdisciplinary Graduate Programs, Professor of Clinical Pharmacy, Titus Family Department of Clinical Pharmacy
Dr. Wong-Beringer joined the faculty at the University of Southern California School of Pharmacy in July 2003 as an Associate Professor of Clinical Pharmacy. She is a graduate of USC School of Pharmacy. She received her postdoctoral residency in pharmacy practice and fellowship training in infectious diseases pharmacotherapy at the University of California, San Francisco. Her clinical practice and research is at Huntington Hospital, Pasadena.
Dr. Wong-Beringer has been a principal investigator on a number of research studies on antimicrobial resistance and bacterial virulence and their impact on patient outcomes. Her research focuses on Pseudomonas aeruginosa and Staphylococcus aureus. Her recent work has expanded to include investigations on the contribution of host immune response and immunogenetics to outcomes of infection. Dr. Wong-Beringer has authored numerous journal articles and book chapters in the area of her clinical expertise and research.